We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$452M
AUM Growth
+$130M
(+40%)
Cap. Flow
-$18.5M
Cap. Flow
% of AUM
-4.08%
Top 10 Holdings %
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
+$3.03M |
| 2 |
OneSpan
OSPN
|
+$2.96M |
| 3 |
Anterix
ATEX
|
+$2.79M |
| 4 |
Calix
CALX
|
+$2.73M |
| 5 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axsome Therapeutics
AXSM
|
+$3.54M |
| 2 |
Karyopharm Therapeutics
KPTI
|
+$3.44M |
| 3 |
Teladoc Health
TDOC
|
+$3.2M |
| 4 |
Krystal Biotech
KRYS
|
+$3M |
| 5 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
+$2.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.95% |
| 2 | Technology | 21.89% |
| 3 | Consumer Discretionary | 16.2% |
| 4 | Industrials | 10.05% |
| 5 | Consumer Staples | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASPU
101
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.85M | 0.41% |
204,677
-119,642
| -37% | -$984K |
|
|
LITS
102
Lite Strategy Inc
LITS
$32.8M
| $1.84M | 0.41% |
+22,241
| New | +$1.35M |
|
103
Monolithic Power Systems
MPWR
$66.1B
| $1.83M | 0.41% |
+7,739
| New | +$1.57M |
|
104
Camping World
CWH
$681M
| $1.83M | 0.4% |
+67,410
| New | +$1.09M |
|
105
Fox Factory Holding Corp
FOXF
$822M
| $1.83M | 0.4% |
+22,137
| New | +$1.38M |
|
|
ARNA
106
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.82M | 0.4% |
+28,971
| New | +$1.59M |
|
107
Vicor
VICR
$10.3B
| $1.81M | 0.4% |
+25,195
| New | +$1.41M |
|
|
ZNGA
108
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.81M | 0.4% |
189,625
-71,642
| -27% | -$588K |
|
109
FIVE9
FIVN
$2.27B
| $1.8M | 0.4% |
16,313
-14,679
| -47% | -$1.43M |
|
110
Coherent
COHR
$65.6B
| $1.8M | 0.4% |
+38,214
| New | +$1.51M |
|
111
Manhattan Associates
MANH
$11.1B
| $1.79M | 0.4% |
+19,030
| New | +$1.42M |
|
112
Kinsale Capital Group
KNSL
$8.37B
| $1.78M | 0.39% |
11,490
-6,691
| -37% | -$891K |
|
|
ONEM
113
DELISTED
1Life Healthcare
ONEM
| $1.78M | 0.39% |
+49,075
| New | +$1.38M |
|
114
KORU Medical Systems
KRMD
$189M
| $1.77M | 0.39% |
197,010
-150,810
| -43% | -$1.52M |
|
115
Sprout Social
SPT
$519M
| $1.75M | 0.39% |
65,017
-91,841
| -59% | -$2.01M |
|
116
Zscaler
ZS
$26.3B
| $1.75M | 0.39% |
16,023
-5,772
| -26% | -$480K |
|
117
BILL Holdings
BILL
$4.84B
| $1.75M | 0.39% |
19,446
-10,416
| -35% | -$671K |
|
118
Ciena
CIEN
$59.2B
| $1.75M | 0.39% |
+32,334
| New | +$1.61M |
|
119
IDEAYA Biosciences
IDYA
$3.5B
| $1.75M | 0.39% |
+122,988
| New | +$969K |
|
120
Thor Industries
THO
$4.14B
| $1.74M | 0.38% |
+16,342
| New | +$1.28M |
|
121
Fate Therapeutics
FATE
$309M
| $1.72M | 0.38% |
50,110
-17,537
| -26% | -$523K |
|
122
Ollie's Bargain Outlet
OLLI
$4.72B
| $1.72M | 0.38% |
+17,587
| New | +$1.35M |
|
|
XLRN
123
DELISTED
Acceleron Pharma
XLRN
| $1.72M | 0.38% |
18,014
-5,745
| -24% | -$554K |
|
124
XPEL
XPEL
$1.38B
| $1.72M | 0.38% |
109,657
-61,078
| -36% | -$835K |
|
|
TWOU
125
DELISTED
2U Inc
TWOU
| $1.71M | 0.38% |
+1,505
| New | +$1.34M |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q2 2020 Portfolio in Review
As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.
- EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
- EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
- EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
- EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
- EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
- EAM Investors opened 147 new positions and closed 97 in Q2 2020.
- EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.
Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.